Mistras Q1 revenue $161.7M (+5.2% organic); net loss $5.4M; Adj. EBITDA $5.5M

Mistras Group, Inc.

2023-Q1 EPS reported -$0.18 revenue$161,662,000

Revenue $161.7M (+5.2% organic); net loss $5.4M unchanged YoY; adjusted EBITDA $5.5M vs $7.0M.
Services revenue $132.9M (+7% YoY); gross margin down 200bps to 23% on higher healthcare costs.
International revenue $28.1M (+7.5% organic in local currency); gross margin up 150bps to 29.1%.
Free cash flow -$8.6M vs -$1.2M; net debt $188.9M vs $178.5M at Dec 31, 2021.
FY2022 guidance: revenue $695-715M, Adj. EBITDA $65-69M, free cash flow $27-30M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.